Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07817563 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Evaluating 68GA-FAPI-46 PET/CT in Patients With Interstitial Lung Disease

Name: Study Evaluating 68GA-FAPI-46 PET/CT in Patients With Interstitial Lung Disease — clinical trial record (NCT07817563)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorMayo Clinic

Started2026-10-16

View on ClinicalTrials.gov ↗

Mayo Clinic

1,015 trials monitored

See 115 trials at risk

The purpose of this research is to better understand the distribution of an investigational radioactive imaging agent called 68Ga-FAPI-46 in the lungs of people with interstitial lung disease (ILD) during a Positron Emission Tomography/Computed Tomography (PET/CT) scan.

Trial Details

NCT Number	NCT07817563
Lead Sponsor	Mayo Clinic
Conditions	Interstitial Lung Disease
Enrollment	10 participants
Start Date	2026-10-16
Primary Completion	2030-05 (estimated)
Study Completion	2031-05 (estimated)
Updated on ClinicalTrials.gov	2026-09-18